Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-13

FDA Approved: CARISOPRODOL — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Carisoprodol from Rising Pharma Holdings, Inc., completing a supplemental approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carisoprodol (Carisoprodol)

Snippet

SUPPL AP for CARISOPRODOL (CARISOPRODOL)